Inhaled anti-rejection drug preserves lung function in lung transplant patients

May 22, 2006

SAN DIEGO--Lung transplant patients who received an inhaled version of the anti-rejection drug cyclosporine had significantly better lung function than those who inhaled a placebo drug in the two years after their transplant, according to a study to be presented at the American Thoracic Society International Conference on May 22nd.

The findings come from the same study that previously found that inhaled cyclosporine improved survival and extended periods of chronic rejection-free survival in lung transplant patients. Those results were published in The New England Journal of Medicine in January 2006.

"Many lung transplant patients develop chronic rejection of the new lung--it is the Achilles heel of the transplant process," said lead researcher Aldo Iacono, M.D., Medical Director of Lung Transplantation at the University of Maryland Medical Center and Associate Professor of Medicine at the University of Maryland School of Medicine in Baltimore. "Typically, patients experience a progressive, inexorable decline in lung function, most likely because of this chronic rejection and infections. This finding that aerosolized cyclosporine preserves lung function bolsters our previous findings that the drug reduces chronic rejection of the lung."

The new study looked at 58 lung transplant patients, who were randomly assigned to inhale either 300 mg of aerosol cyclosporine or aerosol placebo three days a week for the first two years after their transplant. Both groups received oral anti-rejection medicines.

Patients who received the placebo experienced a decline in lung function that was four times as great as those who inhaled the cyclosporine. There was no difference in the rate of acute rejection of the lung (rejection occurring in the first few weeks after surgery) between the two groups.

"Since the early 1990s we have been studying inhaled cyclosporine in lung transplant patients after they experience chronic rejection, but this is the first trial in which inhaled cyclosporine was used soon after the lung transplant occurred, before chronic rejection sets in," Dr. Iacono said.

About 1,700 lung transplants are done at 150 centers around the world each year, but they are among the riskiest types of transplant surgery. Almost half of recipients die within three years, and the long-term survival rate has not changed much in the last 20 years.

Dr. Iacono said that the data on the drug's impact on survival and chronic rejection were presented to the U.S. Food and Drug Administration in June 2005, and that the FDA requested further studies. "I am hoping that the lung transplant community can work together to organize a multi-center trial," he said. "If we find promising results from a new, bigger, trial, and the drug becomes readily available, it could make a big difference for lung transplant patients."
-end-


American Thoracic Society

Related Lung Function Articles from Brightsurf:

Exercised over nothing: Masks don't impair lung function during physical activity
A team of American and Canadian researchers report that while they may feel uncomfortable, there is little empirical evidence that wearing a facemask significantly diminishes lung function, even when worn during heavy exercise.

Lung, immune function in kids could protect from severe COVID-19
Differences in lung physiology and immune function in children could be why they are more often spared from severe illness associated with COVID-19 than adults.

Identification of new factors important in maintaining lung function in the elderly
Japanese researchers have found that elderly carriers of a specific DsbA-L gene type are at increased risk for lung function decline.

Weight gain associated with accelerated lung function decline in adulthood
Lung function declines naturally over the course of the human lifespan.

Inhaled immunosuppressant may increase survival, pulmonary function after lung transplant
University of Maryland School of Medicine researchers found that lung transplant recipients who had early signs of organ rejection could increase their chances of survival by inhaling a liposomal form of the immunosuppression drug cyclosporine through an investigational nebulizer.

Exposure to BPA in the womb linked to wheezing and poorer lung function in children
Pregnant women exposed to higher levels of the commonly used chemical bisphenol A (BPA) are more likely to have children who suffer with wheezing and poorer lung function, according to research presented at the European Respiratory Society International Congress.

Exposure to outdoor air pollutants, change in emphysema, lung function
Whether exposure to outdoor air pollutants is associated with emphysema progression and change in lung function was the focus of this observational study.

Girls who are more physically active in childhood may have better lung function in adolescence
A study of more than 2,300 adolescents underscores the pulmonary health benefits of physical activity.

Exposure to chemicals before and after birth is associated with a decrease in lung function
A European study, published in The Lancet Planetary Health, analyses for the first time the impact of the exposome on respiratory health.

Common e-cigarette chemical flavorings may impair lung function
Two chemicals widely used to flavor electronic cigarettes may be impairing the function of cilia in the human airway, according to a new study led by Harvard T.H.

Read More: Lung Function News and Lung Function Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.